No Data
Dalian BIO-CHEM (SHSE:603360) Seems To Use Debt Quite Sensibly
Announcement of Dalian Baiao Chemical Co., Ltd. on the main operating data for the third quarter of 2024
Dalian Baiao Chemical Co., Ltd. Report for the Third Quarter of 2024
dalian bio-chem (603360.SH): The net income for the first three quarters is approximately 0.254 billion yuan, a decrease of 10.15% year-on-year.
Gelonghui October 29th | Dalian Bio-chem (603360.SH) announced that the revenue in the first three quarters of 2024 was approximately 0.896 billion yuan, a year-on-year increase of 5.26%; the net income attributable to shareholders of the listed company was approximately 0.254 billion yuan, a year-on-year decrease of 10.15%.
dalian bio-chem (603360.SH): Intends to invest 50 million yuan to establish a wholly-owned subsidiary for conducting chemical business.
On October 21st, dalian bio-chem (603360.SH) announced that, based on its global strategy and development needs, the company has decided to make the semiconductor equipment industry a new direction for its strategic development; the fifth meeting of the fifth board of directors approved the proposal of "Regarding the Subsidiary's Intended External Investment and Capital Increase to Hold Controlling Stake in Suzhou XinHuiLian Semiconductor Technology Co., Ltd.", intending to increase its capital by 0.7 billion yuan in Suzhou XinHuiLian Semiconductor Technology Co., Ltd., resulting in direct ownership of 46.6667% equity, and collectively controlling 54.6342% of the voting rights through entrusted voting rights. This proposal still needs further discussion.
Even With A 35% Surge, Cautious Investors Are Not Rewarding Dalian BIO-CHEM Company Limited's (SHSE:603360) Performance Completely
Dalian BIO-CHEM Company Limited's (SHSE:603360) Share Price Boosted 42% But Its Business Prospects Need A Lift TooNo Data
No Data
